Literature DB >> 19725531

Reduced sensitizing capacity of epoxy resin systems: a structure-activity relationship study.

Ida B Niklasson1, Kerstin Broo, Charlotte Jonsson, Kristina Luthman, Ann-Therese Karlberg.   

Abstract

Epoxy resins can be prepared from numerous chemical compositions. Until recently, alternatives to epoxy resins based on diglycidyl ethers of bisphenol A (DGEBA) or bisphenol F (DGEBF) monomers have not received commercial interest, but are presently doing so, as epoxy resins with various properties are desired. Epoxy resin systems are known to cause allergic contact dermatitis because of contents of uncured monomers, reactive diluents, and hardeners. Reactive diluents, for example, glycidyl ethers, which also contain epoxide moieties, are added to reduce viscosity and improve polymerization. We have investigated the contact allergenic properties of a series of six analogues to phenyl glycidyl ether (PGE), all with similar basic structures but with varying carbon chain lengths and degrees of saturation. The chemical reactivity of the compounds in the test series toward the hexapeptide H-Pro-His-Cys-Lys-Arg-Met-OH was investigated. All epoxides were shown to bind covalently to both cysteine and proline residues. The percent depletion of nonreacted peptide was also studied resulting in 88% depletion when using PGE and 46% when using butyl glycidyl ether (5) at the same time point, thus revealing a large difference between the fastest and the slowest reacting epoxide. The skin sensitization potencies of the epoxides using the murine local lymph node assay (LLNA) were evaluated in relation to the observed physicochemical and reactivity properties. To enable determination of statistical significance between structurally closely related compounds, a nonpooled LLNA was performed. It was found that the compounds investigated ranged from strong to weak sensitizers, congruent with the reactivity data, indicating that even small changes in chemical structure result in significant differences in sensitizing capacity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725531     DOI: 10.1021/tx900193s

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  6 in total

1.  Nature-derived epoxy resins: Synthesis, allergenicity, and thermosetting properties of pinoresinol diglycidyl ether.

Authors:  Niamh M O'Boyle; Ida B Niklasson; David J Ponting; Miguel A Ortega; Tina Seifert; Andreas Natsch; Kristina Luthman; Ann-Therese Karlberg
Journal:  Toxicol Ind Health       Date:  2022-04-24       Impact factor: 1.851

Review 2.  In vitro methods for hazard assessment of industrial chemicals - opportunities and challenges.

Authors:  Chin Lin Wong; Sussan Ghassabian; Maree T Smith; Ai-Leen Lam
Journal:  Front Pharmacol       Date:  2015-05-05       Impact factor: 5.810

3.  The Fate of a Hapten - From the Skin to Modification of Macrophage Migration Inhibitory Factor (MIF) in Lymph Nodes.

Authors:  Isabella Karlsson; Kristin Samuelsson; Carl Simonsson; Anna-Lena Stenfeldt; Ulrika Nilsson; Leopold L Ilag; Charlotte Jonsson; Ann-Therese Karlberg
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

4.  KnowTox: pipeline and case study for confident prediction of potential toxic effects of compounds in early phases of development.

Authors:  Andrea Morger; Miriam Mathea; Janosch H Achenbach; Antje Wolf; Roland Buesen; Klaus-Juergen Schleifer; Robert Landsiedel; Andrea Volkamer
Journal:  J Cheminform       Date:  2020-04-14       Impact factor: 5.514

5.  Haptenation of Macrophage Migration Inhibitory Factor: A Potential Biomarker for Contact Hypersensitivity.

Authors:  Lorena Ndreu; Samantha Sasse; Ann-Therese Karlberg; Isabella Karlsson
Journal:  Front Toxicol       Date:  2022-04-06

6.  Characterizing Adduct Formation of Electrophilic Skin Allergens with Human Serum Albumin and Hemoglobin.

Authors:  Lorena Ndreu; Luke N Erber; Margareta Törnqvist; Natalia Y Tretyakova; Isabella Karlsson
Journal:  Chem Res Toxicol       Date:  2020-09-17       Impact factor: 3.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.